Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial

ConclusionsIHT appears slightly more attractive in terms of cost-utility and cost-effectiveness than CAU, although differences in both costs and effects are small especially when viewed from the societal costs perspective. From the health care sector costs perspective, IHT has a higher probability of being cost-effective compared to CAU.Trials registrationNetherlands Trial Register: NTR6151.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research